The FDA has approved an injection in combination with an established oral therapy for the treatment of acute promyelocytic leukemia. READ MORE

News

The FDA has approved an injection in combination with an established oral therapy for the treatment of acute promyelocytic leukemia.

READ MORE

The FDA expanded the approved use of a therapy for metastasized breast cancer with a certain germline genetic mutation.

READ MORE

The FDA has expanded the approval of denosumab for the prevention of skeletal-related events in patients with bone metastasis from multiple myeloma.

READ MORE

Journal of Clinical Pathways provides all of the oncology-related drug FDA approvals and their indications in 2017.

READ MORE